Literature DB >> 11819405

Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma.

Ping He, Zhao-You Tang, Sheng-Long Ye, Bin-Bin Liu.   

Abstract

AIM:To certify the relationship between AFP mRNA and some pathological parameters of hepatocellular carcinoma (HCC).
METHODS: We detected the expression of AFP in mRNA level in tissue samples from 52 patients suffered from HCC by RT-PCR method.
RESULTS: The positive rate of AFP mRNA was 76.9% in the HCC tumor tissues,and 69.4% in the paratumor tissues from the HCC patients with severe cirrhosis.However, in HCC patients without cirrhosis, the positive rate reached 50% in tumor tissues, but no AFP mRNA expression was found in the related paratumor tissues.
CONCLUSION: The AFP protein was specially expressed by HCC cells and mutated hepatocytes.The AFP mRNA was positively related with cirrhosis, but no significant relationship was found between AFP mRNA and tumor size, capsule status and tumor metastasis.

Entities:  

Year:  1999        PMID: 11819405      PMCID: PMC4688518          DOI: 10.3748/wjg.v5.i2.111

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.

Authors:  H S Lee; Y H Chung; C Y Kim
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

2.  Chromosomal localization, structure, and expression of the human alpha-fetoprotein gene.

Authors:  A Dugaiczyk; M E Harper; P P Minghetti
Journal:  Kroc Found Ser       Date:  1985

3.  Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.

Authors:  C B Wong; B M Attar; S S Shimoda
Journal:  Am J Gastroenterol       Date:  1995-06       Impact factor: 10.864

4.  In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.

Authors:  F Kanai; K H Lan; Y Shiratori; T Tanaka; M Ohashi; T Okudaira; Y Yoshida; H Wakimoto; H Hamada; H Nakabayashi; T Tamaoki; M Omata
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

Review 5.  Alpha-fetoprotein in ontogenesis and its association with malignant tumors.

Authors:  G I Abelev
Journal:  Adv Cancer Res       Date:  1971       Impact factor: 6.242

6.  Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.

Authors:  A J Parkinson; B J McMahon; L Zanis; A P Lanier; R B Wainwright
Journal:  Arctic Med Res       Date:  1996-07

7.  Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: evaluation of alpha-fetoprotein as a diagnostic marker.

Authors:  S Songsivilai; T Dharakul; S Senawong
Journal:  Asian Pac J Allergy Immunol       Date:  1995-12       Impact factor: 2.310

8.  Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.

Authors:  F Mawatari; S Tsuruta; A Ido; T Ueki; K Nakao; Y Kato; T Tamaoki; N Ishii; K Nakata
Journal:  Cancer Gene Ther       Date:  1998 Sep-Oct       Impact factor: 5.987

9.  Alpha-fetoprotein expression in hepatocellular carcinoma: a clinical study.

Authors:  G Muguti; N Tait; A Richardson; J M Little
Journal:  J Gastroenterol Hepatol       Date:  1992 Jul-Aug       Impact factor: 4.029

10.  Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.

Authors:  S Y Peng; P L Lai; J S Chu; P H Lee; P T Tsung; D S Chen; H C Hsu
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

View more
  16 in total

1.  Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice.

Authors:  X Y Cao; J Liu; Z R Lian; M Clayton; J L Hu; M H Zhu; D M Fan; M Feitelson
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver.

Authors:  X Y Cao; J Liu; Z R Lian; M Clayton; J L Hu; M H Zhu; D M Fan; M Feitelson
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  Qi Niu; Zhao-You Tang; Zeng-Chen Ma; Lun-Xiu Qin; Lian-Hai Zhang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

4.  Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients.

Authors:  F Liu; J X Li; C M Li; X S Leng
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

5.  Hepatic angiomyolipoma-misdiagnosis as hepatocellular carcinoma: A report of 14 cases.

Authors:  Ding-Rong Zhong; Xiao-Long Ji
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

6.  Preparation and characterization of polyclonal antibodies against ARL-1 protein.

Authors:  Jun-Fei Jin; Liu-Di Yuan; Li Liu; Zhu-Jiang Zhao; Wei Xie
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

7.  Construction and expression of recombined human AFP eukaryotic expression vector.

Authors:  Li-Wang Zhang; Jun Ren; Liang Zhang; Hong-Mei Zhang; Bin Jin; Bo-Rong Pan; Xiao-Ming Si; Yan-Jun Zhang; Zhong-Hua Wang; Yang-Lin Pan; Stephen M Festein
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein.

Authors:  Yan-Ming Zhou; Jia-Mei Yang; Bin Li; Zheng-Feng Yin; Feng Xu; Bin Wang; Peng Liu; Zhi-Min Li
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

9.  Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma.

Authors:  Chae Hong Lim; Seung Hwan Moon; Young Seok Cho; Joon Young Choi; Kyung-Han Lee; Seung Hyup Hyun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-02       Impact factor: 9.236

Review 10.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.